Raymond James Financial’s Bristol-Myers Squibb BMY Stock Holding History

Raymond James Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$238M	Sell	3,921,135 -56,734	-1%	-$3.31M	0.07%	239
2025 Q4	$215M	Buy	3,977,869 +732,075	+23%	+$35.2M	0.07%	257
2025 Q3	$146M	Buy	3,245,794 +2,915	+0.1%	+$136K	0.05%	359
2025 Q2	$150M	Sell	3,242,879 -2,284,240	-41%	-$112M	0.05%	330
2025 Q1	$337M	Buy	5,527,119 +972,353	+21%	+$56.7M	0.13%	142
2024 Q4	$258M	Buy	+4,554,766	New	+$254M	0.1%	191

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial's BMY Position: Q1 2026 in Review

Raymond James Financial reduced its Bristol-Myers Squibb (BMY) stake by 1.4% in Q1 2026, selling an estimated $3.31M and leaving 3,921,135 shares worth $238M. The position accounts for 0.07% of the portfolio, ranked #239.

Raymond James Financial first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $337M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Raymond James Financial held 3,921,135 shares of Bristol-Myers Squibb worth $238M as of Q1 2026.
Raymond James Financial sold 56,734 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.31M.
Bristol-Myers Squibb made up 0.07% of Raymond James Financial's portfolio in Q1 2026, its #239 holding.
Raymond James Financial first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
Raymond James Financial's Bristol-Myers Squibb position peaked at $337M in Q1 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.